(S)-(+)-Dimethindene maleate: Selective M2 Antagonist for Pharmacological Profiling

Executive Summary: (S)-(+)-Dimethindene maleate (CAS 136152-65-3) is a small molecule that antagonizes the muscarinic M2 acetylcholine receptor with high selectivity, showing reduced affinity for M1, M3, and M4 subtypes (APExBIO). It also blocks histamine H1 receptors, making it a dual antagonist suitable for receptor selectivity profiling and pharmacological pathway dissection (internal). The compound is water-soluble at concentrations ≥20.45 mg/mL and exhibits a purity of 98.00% (APExBIO). Research-grade batches are recommended to be used promptly after solution preparation to ensure stability and reproducibility. This reagent is foundational in translational research, particularly in cardiovascular, respiratory, and extracellular vesicle (EV) biomanufacturing workflows (Gong et al., 2025).

Biological Rationale

The muscarinic acetylcholine receptor family, especially the M2 subtype, regulates heart rate, smooth muscle contraction, and central parasympathetic outflow. Selective antagonism of M2 receptors enables precise dissection of autonomic control mechanisms in cardiovascular and respiratory physiology (APExBIO). Histamine H1 receptors are central to allergy, inflammation, and bronchoconstriction; dual antagonists facilitate studies distinguishing cholinergic from histaminergic effects in complex biological systems (internal). The availability of highly selective pharmacological tools is critical for reproducibility and mechanistic clarity in preclinical and translational research (Gong et al., 2025).

Mechanism of Action of (S)-(+)-Dimethindene maleate

(S)-(+)-Dimethindene maleate is a competitive antagonist at the M2 muscarinic acetylcholine receptor. It binds the orthosteric site, preventing acetylcholine from activating downstream G-protein coupled signaling. This leads to inhibition of parasympathetic modulation of heart rate and smooth muscle tone. The compound also competitively inhibits histamine H1 receptors, reducing histamine-mediated vascular permeability and bronchoconstriction (Gong et al., 2025; APExBIO).

The molecular structure (C20H24N2·C4H4O4, MW 408.5) confers high water solubility (≥20.45 mg/mL) and stability under dry, room temperature conditions. However, once in solution, rapid use is recommended due to potential hydrolytic instability (APExBIO).

Evidence & Benchmarks

• Demonstrates >100-fold selectivity for M2 over M1, M3, and M4 muscarinic receptor subtypes under in vitro binding assays (Gong et al., 2025, https://doi.org/10.1186/s13287-025-04507-y).
• Blocks histamine H1-mediated bronchoconstriction in preclinical respiratory models (Gong et al., 2025, https://doi.org/10.1186/s13287-025-04507-y).
• Maintains 98.00% purity (HPLC, APExBIO B6734 product sheet, https://www.apexbt.com/s-dimethindene-maleate.html).
• Stability in solid form is preserved for >12 months at room temperature and desiccated conditions (APExBIO, product page).
• Enables selective pharmacological isolation of autonomic pathways in scalable EV biomanufacturing studies (Gong et al., 2025, https://doi.org/10.1186/s13287-025-04507-y).

This article extends and updates the mechanistic exploration in "(S)-(+)-Dimethindene Maleate: Accelerating Translational ..." by providing new benchmarks on purity, solution stability, and integrative workflow use in EV research. It clarifies the scope set out in "(S)-(+)-Dimethindene Maleate: Precision Tools for Receptor Profiling" by detailing where the compound's selectivity is most robust, and referencing new data from Gong et al. (2025).

Applications, Limits & Misconceptions

Key Applications:

• Autonomic regulation research: dissection of cholinergic vs. non-cholinergic contributions to cardiac and smooth muscle function.
• Cardiovascular physiology studies: mechanistic probing of M2 receptor-mediated heart rate control.
• Respiratory system function research: distinguishing muscarinic from histaminergic bronchoconstriction.
• Receptor selectivity profiling in pharmacological tool validation.
• Scalable EV biomanufacturing: ensuring reproducible isolation of signaling pathways (Gong et al., 2025).

Common Pitfalls or Misconceptions

• Not suitable for long-term solution storage; hydrolysis may reduce activity within hours or days depending on solvent and temperature (APExBIO).
• Does not antagonize muscarinic M5 or adrenergic receptors; specificity is limited to M2, with reduced affinity for M1, M3, and M4 (Gong et al., 2025).
• Not approved for diagnostic or therapeutic use in humans; for research use only (APExBIO product information).
• Ineffective in models where receptor expression is absent or downregulated (e.g., certain knockout models).
• May be confounded by high concentrations of endogenous acetylcholine or histamine in ex vivo systems, requiring careful titration.

Workflow Integration & Parameters

• Supplied as a solid; reconstitute in sterile water (≥20.45 mg/mL) immediately before use for optimal activity (APExBIO).
• Store solid compound desiccated at room temperature; avoid repeated freeze-thaw of solutions.
• Integrates into receptor selectivity profiling platforms and functional assays, including organ bath, patch-clamp, and cell-based signal transduction studies.
• Widely used as a control or reference antagonist in scalable EV biomanufacturing workflows, as demonstrated in Gong et al. (2025) (https://doi.org/10.1186/s13287-025-04507-y).
• For detailed translational protocols, see the APExBIO (S)-(+)-Dimethindene maleate product page.

Conclusion & Outlook

(S)-(+)-Dimethindene maleate, provided by APExBIO (SKU: B6734), is a rigorously characterized, selective M2 muscarinic and H1 histamine receptor antagonist. It enables reproducible pharmacological studies in autonomic regulation, cardiovascular physiology, and EV biomanufacturing. Its use is supported by peer-reviewed evidence and robust product documentation. Ongoing research continues to refine its role as a standard for receptor selectivity profiling and translational workflow integration (Gong et al., 2025).